The AI effect in pharma commercial strategy: From data to re...
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
Novo Nordisk will file semaglutide for MASH next year
Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US
Lexicon's type 1 diabetes drug voted down by FDA adcomm
It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt.
NICE trumpets new standard for health AI evaluations
With artificial intelligence technologies for healthcare on the rise, UK health technology assessment (HTA) agency NICE has published an economic evaluation standard that it says will help
Why language training is crucial for healthcare teams
In today's increasingly globalised world, multilingualism and cultural diversity have become fundamental aspects of modern life.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Europe’s Largest Industry-Led & Dedicated Gathering for mRNA...
The 4th mRNA-Based Therapeutics Summit Europe returns to Frankfurt, Germany as the industry’s premier forum dedicated to showcasing the hottest disease targets,
9th Microbiome Movement Summit Europe
Translating Microbiome R&D into Improved Healthcare Outcomes & Commercial Potential
8th Antigen-Specific Immune Tolerance Drug Development Summi...
Building on 7 years of success, the 8th Antigen-Specific Immune Tolerance Summit is back - the only conference dedicated to advancing curative th
The 8th CAR-TCR Summit Europe: Your European Hub of Next Gen...
Investors in the cell therapy industry are actively looking into solid tumours, autoimmune indications and novel engineering as the best place to allocate their money and resources.
2nd Protein Degradation for CNS Summit | Brand-New Program
Join us at the 2nd Protein Degradation for CNS Summit - an unparalleled event dedicated to delivering protein degraders to undruggable CNS target